Apteka Mandragorasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-02-18
Share capital
50,000.00 PLN
Registered address
Władysława Jagiełły 2, 32-400 Myślenice, Poland
Electronic delivery address
AE:PL-75550-17468-EUEJV-25

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 27 days early.

  • 202527/05/2026
  • 202416/06/2025
  • 202304/06/2024
  • 202226/06/2023
  • 202106/07/2022
  • 202028/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.05mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -15.90kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 1.05mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 241.67kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Apteka Mandragora has been an NFZ healthcare provider since 2008. In 2026 it is performing 2 contracts with a total value of USD 27.01. All its contracts were worth USD 1.13k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmesmałopolskie1USD 27.01
Other services provided in pharmaciesmałopolskie1USD 0.00

Authorized Representatives

Adam Marcin Pecyna – President of the Management Board
Tomasz Płonka – Attorney-in-fact (sole)

Manner of representation

The company is represented by each member of the management board independently.

Ownership

OwnerSharesShare valueStake
1,000$13,506.21100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2004-03-16.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $10,431.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,960
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,891

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
APIS Farmacjasp. z o.o.
Vitasp. z o.o.
Gold Lionsp. z o.o.
Grupa Aptekarska Kujałowiczsp. j.
Herbarium Świętego Franciszkasp. z o.o.
Eurekasp. z o.o.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Twoja Tania Apteka Farmarsp. z o.o.
Nukloversp. z o.o.

Change history

DateEvent
2023-01-31PKD change
2010-02-01Switch to PKD 2007
2004-03-19Address change
2004-02-18Entered in the register

FAQ

Last updated: 2026-10-07